Show simple item record

dc.contributor.authorÇınar, Çiğdem
dc.contributor.authorŞentürk Çiftçi, Hayriye
dc.contributor.authorKıvanç, Demet
dc.contributor.authorDorak, Mehmet Tevfik
dc.contributor.authorOğuz, Fatma
dc.contributor.authorKarakaş, Zeynep
dc.contributor.authorYavuz, Çağla
dc.date.accessioned2021-12-10T12:43:09Z
dc.date.available2021-12-10T12:43:09Z
dc.date.issued2021
dc.identifier.citationYavuz Ç., Oğuz F., Çınar Ç., Şentürk Çiftçi H., Kıvanç D., Karakaş Z., Dorak M. T. , "The Association of PRKRAP1 Pseudogene with Acute Lymphoblastic Leukemia Risk", Journal of Clinical Haematology, cilt.2, sa.1, ss.18-23, 2021
dc.identifier.otherav_d21481b5-e333-4087-86ea-5bc21af91196
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/174505
dc.identifier.urihttps://www.scientificarchives.com/admin/assets/articles/pdf/the-association-of-prkrap1-pseudogene-with-acute--lymphoblastic-leukemia-risk-20210420100408.pdf
dc.description.abstractObjective: Acute Lymphoblastic Leukemia (ALL) consists of excessive proliferation of lymphoblasts. The frequency of Human Leukocyte Antigen (HLA)-DR53 (DRB4) homozygosity and allele was found to be higher in male childhood ALL cases. The aim of this study was to identify the HLA-DR53 allele frequency; interferon-inducing double chain ribonucleic acid binding protein kinase A pseudogene 1 (PRKRAP1) positivity; rs2395185 allele and genotype frequencies in ALL patients. Materials and Methods: Sixty ALL patients and 40 healthy controls were studied. HLA’s were analyzed using the PCR-SSP. The PRKRAP1 positivity have been identified by PCR and rs2395185 genotypes were determined by TaqMan assay using real-time PCR. Results: PRKRAP1 positivity was shown to be specific to HLA-DRB4 haplotype in the whole group. We observed that HLA-DRB1*04, DRB1*07 alleles were higher in male patients (43.5%, 25.0%) compared with female patients (25.0%, 21.4%). The prevalence of rs2395185 T allele, HLA-DRB4 allele and HLA-DRB4 homozygous in childhood ALL patients were significantly higher in males compared with the females (p:0.044, p:0.007, p:0.045, respectively). Conclusion: The molecular mechanism of PRKRAP1 pseudogenesis, which we have confirmed to be specific for HLA-DRB4 (DR53) haplotypes, in a newly identified specific transcription map can be investigated and its relationship with ALL can be determined.
dc.language.isoeng
dc.subjectGeneral Medicine
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectFamily Practice
dc.subjectFundamentals and Skills
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectMedicine (miscellaneous)
dc.subjectHealth Sciences
dc.titleThe Association of PRKRAP1 Pseudogene with Acute Lymphoblastic Leukemia Risk
dc.typeMakale
dc.relation.journalJournal of Clinical Haematology
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Temel Tıp Bilimleri Bölümü
dc.identifier.volume2
dc.identifier.issue1
dc.identifier.startpage18
dc.identifier.endpage23
dc.contributor.firstauthorID2622361


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record